From: Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients
Factors | Relative risk | Test for homogeneity |
---|---|---|
Age (years old) | Â | p = 0.40 |
> 50 | 1.00 (95% CI 0.49-2.10) | Â |
≤ 50 | 0.68 (95% CI 0.39-1.18) |  |
Cisplatin (total dose, mg) | Â | p = 0.57 |
> 600 mg | 0.94 (95% CI 0.59-1.49) | Â |
≤ 600 mg | 0.70 (95% CI 0.28-1.73) |  |
Co-morbidities | Â | p = 0.36 |
Yes | 1.11 (95% CI 0.45-2.78) | Â |
No | 0.69 (95%CI 0.43-1.12) | Â |